Observational Study of Once-Daily Insulin Detemir T2D Aged 75 & over

In both the older and younger age groups, the addition of once-daily insulin detemir to existing OAD regimens was effective and safe. In older patients, an improvement in HbA1c of 1.2 % was not associated with an increased risk of severe hypoglycaemia or weight gain (Drugs and Aging)